Skip to main content
    I

    Immatics NV (IMTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $6.17
    -0.22 (-3.44%)

    Market Cap: $972.99M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Immatics NV (IMTX) Financials: Revenue, Profit and Cash Flow

    Updated Nov 10, 2026. Financial statements from company filings, amounts in EUR.

    Immatics NV reported revenue of EUR 48.27M for the fiscal year ended Dec 31, 2025, down 69.0% from the year before. That year, net income was EUR -196.45M with a net margin of -407.0%, operating cash flow was EUR -169.66M and free cash flow was EUR -175.95M. The quarter ended Sep 30, 2026 had revenue of EUR 6.92M and net income of EUR -76.02M.

    Revenue and Margins

    Over the 7 years to Dec 2025, revenue grew from EUR 3.77M, a compound annual rate of 43.9%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 202548.27M-69.0%100.0%-377.1%-407.0%
    Dec 2024155.84M+188.6%100.0%-24.8%9.8%
    Dec 202354.00M-68.8%100.0%-188.4%-175.3%
    Dec 2022172.83M+397.2%100.0%17.3%16.0%
    Dec 202134.76M+11.2%100.0%-248.2%-268.5%
    Dec 202031.25M+69.4%-114.7%-223.1%-676.0%
    Dec 201918.45M+389.4%-117.3%-178.9%-172.0%
    Dec 20183.77MN/A-801.1%-912.7%-834.1%
    Annual, fiscal years ended Dec 2018 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the company posted a net loss after a profit the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Revenue48.27M155.84M54.00M172.83M34.76M31.25M18.45M3.77M
    Cost of revenueN/A148.08M118.66M106.78M87.57M67.08M40.09M33.97M
    Gross profit48.27M155.84M54.00M172.83M34.76M-35.83M-21.64M-30.20M
    Research and development183.83M148.08M118.66M106.78M87.57M67.08M40.09M33.97M
    Operating income-182.02M-38.62M-101.72M29.95M-86.29M-69.72M-33.01M-34.41M
    Net income-196.45M15.22M-94.65M27.70M-93.33M-211.28M-31.74M-31.44M
    EBITDAN/A34.46M-88.93M50.04MN/A-65.29M-28.46M-30.16M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue6.92M9.14M7.61M19.76M5.19M4.74M18.58M56.25M50.56M18.75M30.27M15.92M
    Gross profit6.92M9.14M7.61M19.76M5.19M4.74M18.58M56.25M50.56M18.75M30.27M15.92M
    Operating income-78.54M-67.20M-66.06M-38.88M-54.63M-53.13M-35.37M903.00K514.00K-26.56M-13.47M-27.71M
    Net income-76.02M-62.49M-57.81M-35.70M-50.55M-70.35M-39.85M44.86M-8.57M-17.99M-2.24M-26.15M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of EUR 2.76M by 343.01M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Total assets562.10M696.15M509.96M407.82M174.65M254.65M134.28M61.32M
    Current assets503.79M629.55M449.37M377.15M152.21M238.99M124.00M55.29M
    Cash and equivalents345.77M236.75M218.47M148.52M132.99M207.53M103.35M39.37M
    Total liabilities78.20M121.30M292.35M204.47M150.58M167.26M175.11M70.49M
    Short-term debt2.76M2.85M2.60M2.16M2.71M1.88M1.41MN/A
    Shareholder equity483.89M574.84M217.62M203.35M24.06M87.39M-41.85M-10.41M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets565.72M485.53M543.83M562.34M518.56M567.30M641.69M696.15M577.23M626.97M653.13M509.96M
    Total liabilities127.22M86.07M87.55M78.24M101.88M102.73M105.09M121.30M194.71M239.08M252.34M292.35M
    Cash and equivalents276.61M232.36M301.65M345.92M334.92M256.63M242.84M236.75M189.20M158.14M122.09M218.47M
    Shareholder equity438.50M399.46M456.28M484.10M416.68M464.57M536.61M574.84M382.53M387.89M400.79M217.62M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Operating cash flow-169.66M-158.03M18.23M100.13M-81.78M-85.61M70.97M20.68M
    Capital expenditures6.30M16.48M30.96M6.21M5.66M7.52M2.23M507.00K
    Free cash flow-175.95M-174.51M-12.73M93.92M-87.44M-93.13M68.73M20.18M
    Investing cash flow196.70M-152.39M-31.39M-209.79M7.49M-15.95M-5.06M-13.51M
    Financing cash flow93.51M319.68M84.52M123.71M-2.61M207.88M-1.86M23.65M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-60.70M-61.20M-42.73M-57.64M-44.70M-39.05M-34.21M-58.48M-33.73M-33.22M-32.60M79.08M
    Capital expenditures802.00KN/A775.54K938.58K1.08M1.56M3.13M1.73M2.80M2.77M9.23M9.29M
    Free cash flow-61.50MN/A-43.51M-58.58M-45.78M-40.61M-37.34M-60.21M-36.53M-35.99M-41.84M69.78M
    Last 12 quarters

    Frequently Asked Questions About IMTX

    What is Immatics NV's annual revenue?

    Immatics NV reported revenue of EUR 48.27M for the fiscal year ended Dec 31, 2025.

    How fast is Immatics NV's revenue growing?

    Revenue was down 69.0% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -34.6%.

    Is Immatics NV profitable?

    No. Immatics NV reported net income of EUR -196.45M for the fiscal year ended Dec 31, 2025, with a net margin of -407.0%.

    How much free cash flow does IMTX generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of EUR -169.66M minus capital expenditures of EUR 6.30M produced free cash flow of EUR -175.95M.

    How much debt does Immatics NV have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of EUR 2.76M and cash and equivalents of EUR 345.77M.